Clinical Pathways
Oncology Clinical Pathways (CPs) are decision-support tools that translate published evidence into standardized treatment process maps to help guide cancer treatment decisions. Molecular testing recommendations are included within the disease specific pathways (when appropriate). Use the disease specific pathways for molecular testing guidance.
Oncology CPs are different from treatment guidelines, as CPs recommend a standard treatment based on efficacy, toxicity, and cost. VA Oncology CPs are developed by an interdisciplinary subject matter expert (SME) group and approved by national program offices.
Brain and Central Nervous System (CNS)
-
Glioblastoma
-
H3 K27M Altered Diffuse Midline Glioma
-
IDH Mutant Astrocytoma
-
Meningioma
-
Oligodendroglioma
-
Primary CNS Lymphoma (CNS-DLBCL)
-
Vestibular Schwannoma
Breast
Gastrointestinal (GI)
-
Ampullary Cancer
-
Anal Cancer
-
Biliary Tract Cancer
-
Colon Cancerin CPRS
-
Esophageal Cancerin CPRS
-
Gastric (Stomach) Cancer
-
GI Neuroendocrine Tumors (NETs)
-
Hepatocellular (Liver) Carcinoma
-
Pancreatic Cancer
-
Rectal Cancer
Genitourinary (Genital and Urinary)
-
Bladder Cancerin CPRS
-
Kidney (Renal) Cancerin CPRS
-
Prostate Cancerin CPRS
Gynecologic
-
Cervical Cancer
-
Gestational Trophoblastic Neoplasia
-
Ovarian and Fallopian Cancer
-
Uterine Cancer
-
Vulvar and Vaginal Cancer
Head and Neck
Hematologic (Blood-Related)
-
Acute Myeloid Leukemia
-
Acute Promyelocytic Leukemia
-
Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
-
Chronic Myeloid Leukemia
-
Classic Hodgkin Lymphoma (Hodgkin Disease)
-
Diffuse Large B-Cell Lymphoma
-
Essential Thrombocytosis
-
Follicular Lymphoma
-
Hairy Cell Leukemia
-
Mantle Cell Lymphoma
-
Marginal Zone Lymphoma
-
Myelodysplastic Syndromes
-
Peripheral T-Cell Lymphoma
-
Plasma Cell Disordersin CPRS
-
Polycythemia Vera
-
Primary and Secondary Myelofibrosis
-
Primary Mediastinal B-Cell Lymphoma
-
Waldenstrom Macroglobulinemia and Lymphoplasmacytic Lymphoma
Lung
-
Lung Cancerin CPRS
-
Lung Carcinoids
-
Mesothelioma
Molecular Testing
Sarcoma
Skin
The symbolin CPRS indicates the clinical pathways that can be found in the CPRS medical record.
Clinical Pathways are reviewed at least quarterly by subject matter experts and updated if changes are made. Previous versions are archived and available to internal users within the VA network on the Clinical Pathways SharePoint.
We appreciate hearing how you use these pathways or suggestions for future refinement. Click on the Pathways Feedback button below if you wish to provide us with feedback on our Clinical Pathways.